Study of Talabostat and Cisplatin in Advanced Melanoma
The purpose of this study is to assess the antitumor activity and safety of the combination of talabostat and cisplatin in patients with metastatic melanoma.
Melanoma|Skin Cancer
DRUG: talabostat (PT-100) tablets|DRUG: cisplatin
The purpose of this study is to assess the antitumor activity and safety of the combination of talabostat and cisplatin in patients with metastatic melanoma.